| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 20 Mar 2025 | 20 Mar 2025 |
| The Board of Directors of the Company in its meeting held today, March 20, 2025 inter alia approved the Unaudited Interim Condensed Consolidated Financial Statements for the nine months period ended December 31, 2024 along with the limited review report issued thereunder. This refers to our disclosure dated March 20, 2025 under Regulation 30 of SEBI (LODR) Regulations, 2015 filed with the exchange along with the Unaudited Interim Condensed Consolidated Financial Statements for the nine months period ended December 31, 2024. In this regard, please note that the Company inadvertently mentioned authorised capital as at December 31, 2024 as Rs. 2,550.00 lakh at note no. 7 of the Condensed Financial Statements instead of Rs. 2,725.00 lakh. (As Per BSE Announcement Dated on: 25/03/2025) | ||
| Board Meeting | 14 Feb 2025 | 11 Feb 2025 |
| GENESYS INTERNATIONAL CORPORATION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve This is to inform you that pursuant to Regulation 29 and other applicable provisions of SEBI (LODR) Regulations 2015 a meeting of the Board of Directors of the Company is scheduled to be held on February 14 2025 to consider and approve the following: a. the Un-audited financial results for the quarter ended December 31 2024. b. Proposal for raising of funds in one or more tranches by way of issuance of equity shares convertible securities debts issue or any other instrument or securities through qualified institutional placement private placements preferential issue or any other permissible modes and / or such other methods or combinations thereof in accordance with the Companies Act 2013 read with the rules notified thereunder and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations 2018 or under the applicable laws subject to such statutory approvals as may be required. c. Convening an Extraordinary General meeting The Board of directors at its meeting held on February 14, 2025 considered and approved un-audited financial results for the quarter ended 31st dec 2024 and enabling resolution for fund raising through QIP and approval of conveying EGM (As Per Bse Announcement Dated on 14.02.2025) | ||
| Board Meeting | 28 Oct 2024 | 22 Oct 2024 |
| GENESYS INTERNATIONAL CORPORATION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 inter alia to consider and approve Pursuant to the provisions under Regulation 29 of SEBI (Listing Obligations and The Board of Directors of the Company at their meeting held today inter alia considered and approved Un-audited financial results (standalone and consolidated for the quarter and half year ended 30th September 2024. Enclosed financial Results and limited review report (As per BSE Announcement Date : 28/10/2024) | ||
| Board Meeting | 14 Aug 2024 | 8 Aug 2024 |
| GENESYS INTERNATIONAL CORPORATION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve GENESYS INTERNATIONAL CORPORATION LTD. has informed BSE that a meeting of the Board of Directors of the Company will be held at registered office on Wednesday August 14 2024 to inter alia consider and approve the Un-audited Financial Results (standalone and consolidated) for the quarter ended June 30 2024. The Board of Directors at their meeting held today has inter alia considered and approved Un-audited Financial results (standalone and consolidated) for quarter ended June 30, 2024 (As Per Bse Announcement Dated on 14.08.2024) | ||
| Board Meeting | 30 May 2024 | 24 May 2024 |
| GENESYS INTERNATIONAL CORPORATION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve This is to inform you that a meeting of the Board of Directors of the Company will be held at registered office on Thursday May 30 2024 to inter alia consider and approve the audited Financial results (standalone and consolidated) for the quarter and financial year ended March 31 2024. In compliance with the provisions of Regulation 30 and 33 of SEBI (LODR) Reg, 2015, we wish to inform you that the Board of Directors of the Company, at their meeting held today has inter alia considered and approved following 1. Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2024 along with the statement of Assets and Liabilities 2. Appointment of M/s Roy Jacob & Co., Company Secretaries as the Secretarial Auditors of the Company for the financial year 2024-25. The Board of Directors at its meeting held today has appointed M/s. Roy Jacob & Co., Company Secretaries as the Secretarial Auditor of the Company for the financial year 2024-25. (As Per BSE Announcement Dated on 30.05.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
